Keyphrases
Macrophage Inflammatory Protein 1α
100%
Collagen-induced Arthritis
100%
Adenosine Receptor Agonists
100%
IB-MECA
63%
Receptor Agonist
27%
Adenosine
27%
Adenosine Receptor Subtypes
27%
Inflammation
18%
Macrophages
18%
Chemokines
18%
Interleukin-12 (IL-12)
18%
Neutrophil Recruitment
18%
Inflammatory Cytokines
9%
Inflammatory Mediators
9%
Interleukin-6
9%
Nitric Oxide
9%
Dose Effect
9%
Chronic Inflammatory Diseases
9%
Anti-inflammatory Cytokines
9%
Arthritis
9%
MRNA Level
9%
Tyrosine
9%
Steady State
9%
Reactive Nitrogen Species
9%
Adenosine Receptors
9%
Ethyl
9%
In Vitro Data
9%
Protein Production
9%
Potent Inhibitor
9%
Acute Inflammatory
9%
Chloro
9%
Anti-inflammatory Effect
9%
Neutrophil Infiltration
9%
A1 Receptor
9%
Alpha-2 Agonists
9%
Abrogation
9%
RAW Macrophages
9%
A3 Receptor
9%
N6-Cyclopentyladenosine
9%
A2A Receptor
9%
Joint Inflammation
9%
A3 Adenosine Receptor Agonist
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Receptor Stimulating Agent
100%
Macrophage Inflammatory Protein 1
100%
Collagen-Induced Arthritis
100%
Piclidenoson
87%
Receptor Agonist
37%
Adenosine
37%
Receptor Subtype
37%
Adenosine Receptor
37%
Macrophage Inflammatory Protein
37%
Inflammation
25%
Chemokine
25%
Arthritis
25%
2 Chloro 6 N Cyclopentyladenosine
25%
Disease
12%
Mouse
12%
Nitric Oxide
12%
Cytokine
12%
Anti-Inflammatory Drug
12%
Reactive Nitrogen Species
12%
3 Nitrotyrosine
12%
Antiinflammatory Activity
12%
Adenosine A2 Receptor
12%
Adenosine A3 Receptor Agonist
12%
Immunology and Microbiology
Agonist
100%
Arthritis
100%
Macrophage Inflammatory Protein 1
100%
Macrophage
33%
Macrophage Inflammatory Protein
33%
Chemokine
22%
Neutrophil
22%
Mouse
11%
Mediator
11%
Interleukin-6
11%
Steady State
11%
Neutrophil Chemotaxis
11%
Inflammatory Cytokine
11%
Inflammatory Disorder
11%
Antiinflammatory Activity
11%